Barclays PLC Has $113.40 Million Stock Holdings in iShares Biotechnology ETF $IBB

Barclays PLC grew its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 61.5% during the 4th quarter, HoldingsChannel reports. The firm owned 671,941 shares of the financial services provider’s stock after purchasing an additional 255,750 shares during the quarter. Barclays PLC’s holdings in iShares Biotechnology ETF were worth $113,403,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Dynamic Wealth Strategies LLC increased its stake in shares of iShares Biotechnology ETF by 16.6% in the 4th quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock valued at $71,000 after purchasing an additional 60 shares during the last quarter. Flagship Private Wealth LLC increased its stake in shares of iShares Biotechnology ETF by 2.0% in the 4th quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock valued at $521,000 after purchasing an additional 60 shares during the last quarter. Larson Financial Group LLC increased its stake in shares of iShares Biotechnology ETF by 2.3% in the 4th quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock valued at $458,000 after purchasing an additional 60 shares during the last quarter. Webster Bank N. A. increased its stake in shares of iShares Biotechnology ETF by 1.0% in the 4th quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock valued at $1,093,000 after purchasing an additional 62 shares during the last quarter. Finally, Choreo LLC increased its stake in shares of iShares Biotechnology ETF by 2.2% in the 4th quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock valued at $514,000 after purchasing an additional 65 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.9%

Shares of IBB opened at $172.17 on Tuesday. iShares Biotechnology ETF has a 52-week low of $123.61 and a 52-week high of $179.64. The business’s fifty day moving average is $170.34 and its 200-day moving average is $170.66.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Monday, June 15th will be paid a $0.0238 dividend. The ex-dividend date is Monday, June 15th. This represents a $0.10 annualized dividend and a dividend yield of 0.1%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.